모시는글 프로그램 초록접수 사전등록 발표자 안내 발표자 안내 행사장안내 숙박안내 홈

일반연제 발표 유의사항

일반연제 발표자는 반드시 발표 슬라이드(파워포인트)를 사전에 제출하셔야 발표가 가능합니다.
슬라이드를 기한 내에 제출하지 않을 경우에는 발표불가능으로 간주합니다.
발표 슬라이드수는 15매 이내로 1장 당 10줄 이내로 제작하시는 것을 권장하며, 지정된 10분 발표시간(8분 토의-2분 질의응답)을 정확히 지켜주시기 바랍니다.

1. 파일 제출마감일 : 9월 22일 (월)
2. 파일 형태 : 파워포인트
3. 제출 방법 : ppt1@ksog.org

구연 - 전체   /    모체태아의학   /    생식내분비학   /    부인종양학   /    일반부인과학

[ 구연 - 부인종양학 ]

2008년 9월 26일(금)

Convention Hall C (4F)
시간 번호 성명 소속 제목
좌장 : 백원영(경상의대)
12:30~13:10 GO1 주웅 이화의대 TP 53 restoration using E6/E7 siRNA potentiates therapeutic effect of cisplatin in cervical squamous cell carcinoma
GO2 이성종 가톨릭의대 Distribution of human papillomavirus type 58 variants in progression of cervical dysplasia in Korean women
GO3 전시원 이화의대 The association between MCP-1 and CCR2 single nucleotide polymorphisms and cervical intraepithelial neoplasia and cervical cancer in Korean women
GO4 조한별 연세의대 Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumor marker for cervical neoplasia
좌장 : 허준용(고려의대)
13:10~13:50 GO5 이대우 연세의대 Clinical significance of tumor volume and lymph node involvement assessed by MRI in cervical cancer patients treated with concurrent chemotherapy and radiotherapy
GO6 이유영 성균관의대 The role of the maximal standardized uptake value (SUVmax) in positron emission tomography (PET) in early cervical cancer
GO7 김윤환 서울의대 Adjuvant concurrent chemoradiotherapy-induced neutropenia as a prognostic factor in high-risk cervical cancer
GO8 김희승 서울의대 Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis
좌장 : 오성택(전남의대)
13:50~14:30 GO9 강희석 성균관의대 Relative high dose topotecan combined with carboplatin in recurrent epithelial ovarian cancer (EOC)
GO10 김수현 포천중문의대 Gemcitabine-carboplatin-paclitaxel combination as first-line chemotherapy in advanced ovarian cancer
GO11 이성하 가톨릭의대 Serial pattern of CA125 levels as a predictive value of recurrence in advanced epithelial ovarian cancer
GO12 김미경 서울의대 Neoadjuvant chemotherapy for stage III or IV ovarian cancer : Effects on optimal debulking rates and survival
14:30~15:00   Coffee Break
좌장 : 김장흡(가톨릭의대)
15:00~15:40 GO13 박정열 울산의대 Comparison of laparoscopic radical hysterectomy and abdominal radical hysterectomy for stage IA2-IIA cervical cancer: A matched case-control study
GO14 윤종숙 가톨릭의대 Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer
GO15 박진영 아주의대 Are the adjuvant chemoradiation using 3 ~ 4 cycles of 5-FU/Cisplatin adequate enough for all cervical cancer patients with high risk for treatment failure after radical hysterectomy?
GO16 강우대 전남의대 A clinical analysis of abnormal cervical cancer screening in private clinics
좌장 : 류철희(전북의대)
15:40~16:20 GO17 김기형 부산의대 AZD6244 (ARRY-142886), a Potent MEK 1/2 Inhibitor, induces Selective Growth inhibition in Epithelial Ovarian cancer cells
GO18 이선주 건국의대 Combined effect of protein kinase B inhibitor or extracellular signal-regulated kinase inhibitor against farnesyltransferase inhibition-induced apoptosis in SiHa cells
GO19 전섭 순천향의대 Promoter methylation of runx3 gene in endometrial cancer
GO20 신소진 계명의대 Enhanced expression of transcription factor Nrf2 by isoliquiritigenin (ISL) in uterine leiomyoma cells.
좌장 : 김석현(서울의대)
16:20~17:00 GO21 한호섭 관동의대 Laparoscopic-assisted vaginal hysterectomy vs. abdominal hysterectomy in endometrial cancer
GO22 전영은 연세의대 Leukocyte differential count as a diagnostic and prognostic factor in endometrial cancer
GO23 김민정 서울의대 What do Korean breast cancer patients need for sexual activity?
GO24 기경도 경희의대 Pulmonary toxicity after a quick course of combinatorial vincristine, bleomycin, and cisplatin neoadjuvant chemotherapy in cervical cancer